Javascript must be enabled to continue!
Atroposelective Chan-Evans-Lam Amination
View through CrossRef
The synthetic control of atropoisomerism along C─N bonds is a major challenge, and methods that allow C─N atroposelective bond formation are rare. This is a problem because each atropoisomer can feature starkly differentiated biological properties. Yet, among the three most practical and applicable classical amination methods available: 1) the Cu-catalyzed Ullmann-Goldberg reaction, 2) the Pd-catalyzed Buchwald-Hartwig reaction, and 3) the Cu-catalyzed Chan-Evans-Lam reaction, none has truly been rendered atroposelective at the newly formed C─N bond. The first ever Chan-Evans-Lam atroposelective amination is herein described with a simple copper catalyst and new PyrOx chiral ligand. This method constitutes a change of paradigm in the field.
American Chemical Society (ACS)
Title: Atroposelective Chan-Evans-Lam Amination
Description:
The synthetic control of atropoisomerism along C─N bonds is a major challenge, and methods that allow C─N atroposelective bond formation are rare.
This is a problem because each atropoisomer can feature starkly differentiated biological properties.
Yet, among the three most practical and applicable classical amination methods available: 1) the Cu-catalyzed Ullmann-Goldberg reaction, 2) the Pd-catalyzed Buchwald-Hartwig reaction, and 3) the Cu-catalyzed Chan-Evans-Lam reaction, none has truly been rendered atroposelective at the newly formed C─N bond.
The first ever Chan-Evans-Lam atroposelective amination is herein described with a simple copper catalyst and new PyrOx chiral ligand.
This method constitutes a change of paradigm in the field.
Related Results
Analysis of the Validity of Urine LAM ELISA for Tuberculosis Infection
Analysis of the Validity of Urine LAM ELISA for Tuberculosis Infection
Objective: To explore the validity of urinary lipoarabinomannan (LAM) enzyme-linked immunosorbent assay (ELISA) assay technology for detecting MTB infection in the double infection...
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Abstract 1624: Stat1 promotes lesion growth and tumor immunity of tuberin-deficient cells in lymphangioleiomyomatosis
Abstract 1624: Stat1 promotes lesion growth and tumor immunity of tuberin-deficient cells in lymphangioleiomyomatosis
Abstract
Lymphangioleiomyomatosis (LAM) is a cystic lung disease that primarily affects women, with an estimated global prevalence of 19 per million women. LAM is ca...
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
Abstract
Background
This study aimed to determine the impact of pulmonary complications on death after surgery both before and d...
Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
PURPOSE
As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best perfor...
Exploring the Role of Matrix Metalloproteinases as Biomarkers in Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex. A Pilot Study
Exploring the Role of Matrix Metalloproteinases as Biomarkers in Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex. A Pilot Study
Background: Lymphangioleiomyomatosis can develop in a sporadic form (S-LAM) or in women with tuberous sclerosis complex (TSC). The matrix metalloproteinases (MMPs) are extracellula...
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
Abstract
Background
Postoperative acute kidney injury (AKI) is a common complication of major gastrointestinal surgery with an i...
Impact of postoperative acute kidney injury in patients undergoing major gastrointestinal surgery on 1-year survival and renal outcomes: a national multicentre cohort study
Impact of postoperative acute kidney injury in patients undergoing major gastrointestinal surgery on 1-year survival and renal outcomes: a national multicentre cohort study
Abstract
Background
The intermediate-term impact of acute kidney injury (AKI) in patients after major gastrointestinal and liver...

